Psychemedics Corporation (PMDI)
Psychemedics Corporation is a healthcare company whose common stock is listed on OTC Markets under the symbol PMDI. Through itself and its subsidiaries, the company provides hair-sample testing services for the detection of drugs of abuse and certain health markers in the United States and internationally. Its testing portfolio includes screening and confirmation services using mass spectrometry for substances such as cocaine, marijuana, PCP, amphetamines, opioids, synthetic cannabinoids, benzodiazepines, nicotine, fentanyl and fentanyl analogs, and alcohol. The company’s results can provide both quantitative information and longer-term historical indicators of drug use patterns. Psychemedics serves employers for applicant and employee screening, as well as treatment professionals, law enforcement agencies, school administrators, and parents concerned about drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-PMDI
|
—
|
—
|
—
|
—
|
—
|
—
|
Great
|
—
|
—
|
—
|
0.0%
|
August 12, 2026
|
—
|
—
|
—
|
15.237 M
|
—
|
—
|
—
|
—
|
—
|
—
|